Résultats de la recherche - 1 result

A dose-escalation study of combretastatin A4-phosphate in healthy dogs.

seem to be well tolerated. The severity of the neurotoxicity observed at 100 mg m(-2), although transient, does not invite to use this dose in canine oncology patients. Health Topics:  Animal health ...

QR code

QR code for this page URL